Kidney Week

Abstract: PO2614

Renin Does Not Associate with Mortality or AKI in Acute Respiratory Distress Syndrome

Session Information

• AKI Epidemiology, Risk Factors, and Prevention: Basic Science
  October 22, 2020 | Location: On-Demand
  Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

• 101 AKI: Epidemiology, Risk Factors, and Prevention

Authors

• Mccoy, Ian, Stanford University School of Medicine, Palo Alto, California, United States

Ian Mccoy,

• Matthay, Michael, University of California San Francisco, San Francisco, California, United States

Michael Matthay,

• Abbott, Jason, University of California San Francisco, San Francisco, California, United States

Jason Abbott,

• Hsu, Chi-yuan, University of California San Francisco, San Francisco, California, United States

Chi-yuan Hsu,

• Liu, Kathleen D., University of California San Francisco, San Francisco, California, United States

Kathleen D. Liu,

Background

Renin may be a marker of severity of illness and mortality in critically ill patients. Angiotensin II infusions in patients with lower renin levels may increase the rate of renal recovery from dialysis-requiring AKI. Given that most ACE is found in the lungs and an ACE defect would lead to higher renin levels, we tested associations between renin and clinical outcomes in patients with acute respiratory distress syndrome (ARDS).

Methods

We studied 63 patients with plasma renin measurements enrolled in a phase 1/2 trial of bone marrow-derived human MSCs for moderate-severe ARDS. We estimated associations between renin levels (as a continuous variable) and ARDS severity (assessed by PaO₂/FiO₂), mean arterial pressure (MAP), and serum creatinine at randomization. We then examined if renin was associated with subsequent AKI (defined as ≥ 2x ↑ SCr or new dialysis) or in-hospital mortality.

Results

The median renin was 72 pg/mL (25^th-75^th percentile 33-181 pg/mL). At randomization, there was no cross-sectional correlation between renin level and PaO₂/FiO₂ (R² = 0.03, 95% CI 0.00-0.14, p = 0.21), between renin level and MAP (R² = 0.01, 95% CI 0.00-0.12, p = 0.35), or between renin level and serum creatinine (R² = 0.003, 95% CI 0.00-0.08, p = 0.68). In longitudinal unadjusted analysis, renin did not significantly associate with AKI (OR 1.006 per 10 pg/mL increase, 95% CI 0.992-1.021, p = 0.41) or 28-day mortality (OR 1.000 per 10 pg/mL, 95% CI 0.987-1.014, p = 0.97). Results were similar in adjusted analyses. Serum creatinine at randomization was associated with AKI (OR 3.27 per mg/dL, 95% CI 1.47-7.30, p = 0.004).

Conclusion

We did not find that renin level is a risk factor for mortality or AKI in moderate-severe ARDS.

ARDS Patient Characteristics

Continuous values given as mean (SD). AKI and AKI-D percentages are reported from among the 55 patients not on dialysis at the time of randomization.

Funding

• NIDDK Support